Knapper S - Search Results

1

Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux.

Nicholson R, Menezes AC, Azevedo A, Leckenby A, Davies S, Seedhouse C, Gilkes A, Knapper S, Tonks A, Darley RL. Nicholson R, et al. Among authors: knapper s. Front Oncol. 2022 May 30;12:840046. doi: 10.3389/fonc.2022.840046. eCollection 2022. Front Oncol. 2022. PMID: 35707351 Free PMC article.

2

The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases.

Knapper S, Mills KI, Gilkes AF, Austin SJ, Walsh V, Burnett AK. Knapper S, et al. Blood. 2006 Nov 15;108(10):3494-503. doi: 10.1182/blood-2006-04-015487. Epub 2006 Jul 25. Blood. 2006. PMID: 16868253 Free article.

3

The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse.

Coles SJ, Gilmour MN, Reid R, Knapper S, Burnett AK, Man S, Tonks A, Darley RL. Coles SJ, et al. Among authors: knapper s. Leukemia. 2015 Sep;29(9):1952-4. doi: 10.1038/leu.2015.62. Epub 2015 Mar 9. Leukemia. 2015. PMID: 25748687 No abstract available.

4

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.

Khan N, Hills RK, Virgo P, Couzens S, Clark N, Gilkes A, Richardson P, Knapper S, Grimwade D, Russell NH, Burnett AK, Freeman SD. Khan N, et al. Among authors: knapper s. Leukemia. 2017 May;31(5):1059-1068. doi: 10.1038/leu.2016.309. Epub 2016 Oct 31. Leukemia. 2017. PMID: 27795558 Free PMC article. Clinical Trial.

5

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML.

Knapper S, Russell N, Gilkes A, Hills RK, Gale RE, Cavenagh JD, Jones G, Kjeldsen L, Grunwald MR, Thomas I, Konig H, Levis MJ, Burnett AK. Knapper S, et al. Blood. 2017 Mar 2;129(9):1143-1154. doi: 10.1182/blood-2016-07-730648. Epub 2016 Nov 21. Blood. 2017. PMID: 27872058 Free PMC article. Clinical Trial.

6

Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.

Alanazi B, Munje CR, Rastogi N, Williamson AJK, Taylor S, Hole PS, Hodges M, Doyle M, Baker S, Gilkes AF, Knapper S, Pierce A, Whetton AD, Darley RL, Tonks A. Alanazi B, et al. Among authors: knapper s. Leukemia. 2020 Feb;34(2):427-440. doi: 10.1038/s41375-019-0596-4. Epub 2019 Oct 14. Leukemia. 2020. PMID: 31611628 Free PMC article.

7

Molecular MRD status and outcome after transplantation in NPM1-mutated AML.

Dillon R, Hills R, Freeman S, Potter N, Jovanovic J, Ivey A, Kanda AS, Runglall M, Foot N, Valganon M, Khwaja A, Cavenagh J, Smith M, Ommen HB, Overgaard UM, Dennis M, Knapper S, Kaur H, Taussig D, Mehta P, Raj K, Novitzky-Basso I, Nikolousis E, Danby R, Krishnamurthy P, Hill K, Finnegan D, Alimam S, Hurst E, Johnson P, Khan A, Salim R, Craddock C, Spearing R, Gilkes A, Gale R, Burnett A, Russell NH, Grimwade D. Dillon R, et al. Among authors: knapper s. Blood. 2020 Feb 27;135(9):680-688. doi: 10.1182/blood.2019002959. Blood. 2020. PMID: 31932839 Free PMC article. Clinical Trial.

8

Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo.

Rastogi N, Baker S, Man S, Uger RA, Wong M, Coles SJ, Hodges M, Gilkes AF, Knapper S, Darley RL, Tonks A. Rastogi N, et al. Among authors: knapper s. Br J Haematol. 2021 Apr;193(1):155-159. doi: 10.1111/bjh.17125. Epub 2020 Sep 30. Br J Haematol. 2021. PMID: 32996123 Free PMC article.

9

Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients.

Dennis M, Thomas IF, Ariti C, Upton L, Burnett AK, Gilkes A, Radia R, Hemmaway C, Mehta P, Knapper S, Clark RE, Copland M, Russell N, Hills RK. Dennis M, et al. Among authors: knapper s. Blood Adv. 2021 Dec 28;5(24):5621-5625. doi: 10.1182/bloodadvances.2021005038. Blood Adv. 2021. PMID: 34597366 Free PMC article. Clinical Trial.

10

A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia.

Coats T, Bean D, Basset A, Sirkis T, Brammeld J, Johnson S, Thomas I, Gilkes A, Raj K, Dennis M, Knapper S, Mehta P, Khwaja A, Hunter H, Tauro S, Bowen D, Jones G, Dobson R, Russell N, Dillon R. Coats T, et al. Among authors: knapper s. Br J Haematol. 2022 Mar;196(6):1337-1343. doi: 10.1111/bjh.18013. Epub 2021 Dec 26. Br J Haematol. 2022. PMID: 34957541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page